Trader anxieties have brought about a selloff in professional medical product makers, sending iShares US Medical Products Trade-traded fund down seven per cent this 12 months. Fund administrators may well still be worried about investing in shares perceived to generally be Amongst the “GLP-1 losers,” explained HSBC analyst Rajesh Kumar.Wegovy F